- Home
- BBOT vs UVE Comparison
BBOT vs UVE Comparison
Compare BBOT & UVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBOT | UVE |
|---|---|---|
| Founded | 2016 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 925.9M |
| IPO Year | N/A | 1992 |
Fundamental Metrics
Financial Performance| Metric | BBOT | UVE |
|---|---|---|
| Price | $12.33 | $33.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | $23.80 | ★ $40.00 |
| AVG Volume (30 Days) | ★ 194.2K | 163.1K |
| Earning Date | 11-12-2025 | 10-23-2025 |
| Dividend Yield | N/A | ★ 2.28% |
| EPS Growth | N/A | ★ 70.32 |
| EPS | N/A | ★ 4.23 |
| Revenue | N/A | ★ $1,580,798,000.00 |
| Revenue This Year | N/A | $1.87 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.99 |
| Revenue Growth | N/A | ★ 4.61 |
| 52 Week Low | $8.50 | $18.72 |
| 52 Week High | $14.87 | $35.84 |
Technical Indicators
Market Signals| Indicator | BBOT | UVE |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 54.88 |
| Support Level | N/A | $32.50 |
| Resistance Level | N/A | $35.19 |
| Average True Range (ATR) | 0.00 | 0.92 |
| MACD | 0.00 | 0.13 |
| Stochastic Oscillator | 0.00 | 64.30 |
Price Performance
Historical ComparisonAbout BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.
About UVE UNIVERSAL INSURANCE HOLDINGS INC
Universal Insurance Holdings Inc is a private personal residential homeowner insurance company. The company develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners' lines of business and performs substantially all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The company generates revenue from the collection of premiums, earned net interest and dividend income from the investment portfolio, the collection of reinsurance recoverable and financing fees. The company's primary insurance subsidiaries, (UPCIC) and (APPCIC) provide insurance for personal residential: homeowners, renters/tenants, condo unit owners, and other related coverages.